Concise Review: Mesenchymal Stem Cell Treatment of the Complications of Diabetes Mellitus
Vladislav Volarević(University of Kragujevac), Miodrag Stojković(Centro de Investigacion Principe Felipe), Nebojša Arsenijević(University of Kragujevac), Miodrag L. Lukić(University of Kragujevac)
Cited by 286
Related Papers
Mesenchymal Stem Cell-Derived Exosomes and Other Extracellular Vesicles as New Remedies in the Therapy of Inflammatory Diseases
|Cells|2019|774
IL-1 family nomenclature
|Nature Immunology|2010|341
Interleukin‐33/ST2 axis promotes breast cancer growth and metastases by facilitating intratumoral accumulation of immunosuppressive and innate lymphoid cells
|International Journal of Cancer|2013|326
<scp>IL</scp>‐33 attenuates EAE by suppressing <scp>IL</scp>‐17 and <scp>IFN</scp>‐γ production and inducing alternatively activated macrophages
|European Journal of Immunology|2012|304
IL-33/ST2 axis in inflammation and immunopathology
|Immunologic Research|2012|259